Strategic EP, LLC's Ownership in Alaunos Therapeutics, Inc.

Strategic EP, LLC has filed a Schedule 13G with the SEC, disclosing its ownership of 149,827 shares of Common Stock in Alaunios Therapeutics, Inc., representing 6.8% of the total outstanding shares. The filing also mentions that Strategic EP, LLC holds 62,299 shares of Common Stock issuable upon exercise of pre-funded warrants, which are subject to ownership limitations. A Standstill Agreement was entered into on August 26, 2025, allowing Strategic EP, LLC to exceed the 4.99% ownership limitation, up to 9.99%, as per the pre-funded warrant agreement. The Reporting Person has waived any rights to engage in takeover-related activities or influence the Issuer.